LGM
KURA icon

Logos Global Management’s Kura Oncology KURA Stock Holding History

Logos Global Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300,000
Closed -$6.4M – 68
2024
Q1 		$6.4M Buy
+300,000
New +$5.83M 0.52% 42
2023
Q3 		– Sell
-500,000
Closed -$5.29M – 66
2023
Q2 		$5.29M Buy
+500,000
New +$5.91M 0.72% 39

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Logos Global Management's KURA Position: Q2 2024 in Review

Logos Global Management sold out of Kura Oncology (KURA) in Q2 2024, closing a stake of 300,000 shares — an estimated $6.4M sold.

Logos Global Management first reported a position in KURA in Q2 2023 and held it in 2 quarters. The position peaked at $6.4M in Q1 2024. 174 funds tracked by Wall St. Rank hold KURA as of Q2 2024.

  • Logos Global Management reported no remaining Kura Oncology position as of Q2 2024 after selling out during the quarter.
  • Logos Global Management sold 300,000 Kura Oncology shares in Q2 2024, an estimated $6.4M.
  • Logos Global Management first reported a position in Kura Oncology in Q2 2023 and held it in 2 quarters.
  • Logos Global Management's Kura Oncology position peaked at $6.4M in Q1 2024.
  • 174 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2024.

Based on Logos Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.